Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyVax + GM-CSF in fNHL
NCT00510471Phase 2Terminated
- Sponsor
- Genitope Corporation
- Start
- May 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MyVax in follicular lymphoma (FL), sponsored by Genitope Corporation. Started May 2007; status: terminated.
02
Drugs
MyVax
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00510471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510471.